TY - JOUR
T1 - Anatomical and Dose Changes of Gross Tumour Volume and Parotid Glands for Head and Neck Cancer Patients during Intensity-modulated Radiotherapy
T2 - Effect on the Probability of Xerostomia Incidence
AU - Marzi, S.
AU - Pinnarò, P.
AU - D'Alessio, D.
AU - Strigari, L.
AU - Bruzzaniti, V.
AU - Giordano, C.
AU - Giovinazzo, G.
AU - Marucci, L.
PY - 2012/4
Y1 - 2012/4
N2 - Aims: To quantify the changes in dose as well as in the prediction of parotid gland toxicity due to anatomical changes during therapy of head and neck cancer patients. Materials and methods: Fifteen patients with advanced locoregional head and neck cancer, with no evidence of distant metastasis, were enrolled in a prospective study. All patients were treated with intensity-modulated radiotherapy. Multiple computed tomography scans were repeated at the end of each treatment week. The original treatment plans were copied to the per-treatment scans to create hybrid plans. The normal tissue complication probability (NTCP) was calculated assuming the end point to be grade ≥3 xerostomia according to the Radiation Therapy Oncology Group late toxicity scale. Results: The gross tumour volume dose coverage was slightly affected by the anatomical changes, whereas the mean dose (D mean) to the parotids changed from 26.1 ± 6.0 to 27.4 ± 7.4 Gy, with a mean increase of 0.22 Gy/treatment week. Consequently, the mean NTCP increased from 0.15 ± 0.06 to 0.18 ± 0.10, primarily due to a few patients exhibiting a marked increase. The absolute gross tumour volume shrinkage and the percentage parotids shrinkage were the best independent predictors for the NTCP variations. Conclusions: On average, the increase in the parotids D mean as well as in NTCP during treatment is limited, and the observed variations were strongly patient-dependent.
AB - Aims: To quantify the changes in dose as well as in the prediction of parotid gland toxicity due to anatomical changes during therapy of head and neck cancer patients. Materials and methods: Fifteen patients with advanced locoregional head and neck cancer, with no evidence of distant metastasis, were enrolled in a prospective study. All patients were treated with intensity-modulated radiotherapy. Multiple computed tomography scans were repeated at the end of each treatment week. The original treatment plans were copied to the per-treatment scans to create hybrid plans. The normal tissue complication probability (NTCP) was calculated assuming the end point to be grade ≥3 xerostomia according to the Radiation Therapy Oncology Group late toxicity scale. Results: The gross tumour volume dose coverage was slightly affected by the anatomical changes, whereas the mean dose (D mean) to the parotids changed from 26.1 ± 6.0 to 27.4 ± 7.4 Gy, with a mean increase of 0.22 Gy/treatment week. Consequently, the mean NTCP increased from 0.15 ± 0.06 to 0.18 ± 0.10, primarily due to a few patients exhibiting a marked increase. The absolute gross tumour volume shrinkage and the percentage parotids shrinkage were the best independent predictors for the NTCP variations. Conclusions: On average, the increase in the parotids D mean as well as in NTCP during treatment is limited, and the observed variations were strongly patient-dependent.
KW - Head and neck cancer
KW - Intensity-modulated radiotherapy
KW - Normal tissue complication probability
KW - Parotid glands
UR - http://www.scopus.com/inward/record.url?scp=84857914573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857914573&partnerID=8YFLogxK
U2 - 10.1016/j.clon.2011.11.006
DO - 10.1016/j.clon.2011.11.006
M3 - Article
C2 - 22138192
AN - SCOPUS:84857914573
VL - 24
JO - Clinical Oncology
JF - Clinical Oncology
SN - 0936-6555
IS - 3
ER -